Sign Up to like & get
recommendations!
1
Published in 2017 at "Cell metabolism"
DOI: 10.1016/j.cmet.2017.04.013
Abstract: Glucagon-like peptide-1 (GLP-1)-based therapies control glycemia in type 2 diabetic (T2D) patients. However, in some patients the treatment must be discontinued, defining a state of GLP-1 resistance. In animal models we identified a specific set…
read more here.
Keywords:
gut brain;
gut;
glp resistance;
Sign Up to like & get
recommendations!
1
Published in 2019 at "Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy"
DOI: 10.2147/dmso.s215789
Abstract: Purpose Myocardia in diabetic patients exhibit increased vulnerability after ischemia/reperfusion injury (IRI). It has been demonstrated that glucagon-like peptide-1 (GLP-1) has a protective effect on cardiomyocytes. Protein kinase C (PKC) acts as a key regulator…
read more here.
Keywords:
overexpression pkc;
glp resistance;
glp;
pkc ... See more keywords